

Self · Praxis Precision Medicines, Inc. · Praxis Precision Medicines, Inc. - Common Stock
Purchase
Disclosed range starting at $1K
Disclosed 36 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Gilbert Ray Cisneros, Jr.DSelf | Purchase | BUY | $1,001 – $15K | Oct 12, 2026 traded Sep 29, 2026 | |
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $309K 999 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 0 | DeSimone JillDirector | Option exercise · 10b5-1 plan | M | — 8,566 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $210K 683 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $382K 1,240 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $544K 1,750 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $314K 1,004 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $158K 504 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 19 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $264K 837 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 0 | DeSimone JillDirector | Option exercise · 10b5-1 plan | M | — 3,034 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 5 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $36K 120 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 17 | DeSimone JillDirector | Option exercise · 10b5-1 plan | M | $379K 8,566 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 13 | DeSimone JillDirector | Option exercise · 10b5-1 plan | M | $447K 3,034 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 5 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $3,014 10 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 8 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $98K 320 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 19 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $890K 2,854 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 19 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $403K 1,279 sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 12 | Mastrocola LaurenPrincipal Accounting Officer | Tax withholding | F | $95K 344 sh | Jan 13, 2026 traded Jan 12, 2026 | |
| 12 | Sniecinski MeganChief Operating Officer | Tax withholding | F | $244K 885 sh | Jan 13, 2026 traded Jan 12, 2026 | |
| 15 | Kelly Timothy EdwinChief Financial Officer | Tax withholding | F | $260K 943 sh | Jan 13, 2026 traded Jan 12, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Gilbert Ray Cisneros, Jr. reported a purchase of Praxis Precision Medicines, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Recorded votes from the House Clerk and Voteview (Senate). Listed by date; a vote near a trade is not evidence the two are related.